VERACYTE, INC. Business Acquisition, Pro Forma Net Income (Loss)
VERACYTE, INC. (VCYT) reported Business Acquisition, Pro Forma Net Income (Loss) of -$29.09 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2017-03-01
- VERACYTE, INC. business acquisition, pro forma net income (loss) for the quarter ending 2014-12-31 was -$7.66M.
- VERACYTE, INC. business acquisition, pro forma net income (loss) for the quarter ending 2014-09-30 was -$6.45M.
- VERACYTE, INC. business acquisition, pro forma net income (loss) for the quarter ending 2013-12-31 was -$5.58M.
- VERACYTE, INC. business acquisition, pro forma net income (loss) for the quarter ending 2013-09-30 was -$8.22M.
- VERACYTE, INC. business acquisition, pro forma net income (loss) for fiscal 2015 was -$29.09M.
- VERACYTE, INC. business acquisition, pro forma net income (loss) for fiscal 2014 was -$28.61M.
- VERACYTE, INC. business acquisition, pro forma net income (loss) for fiscal 2013 was -$28.61M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2015-12-31 | -$29.09M 10-K · filed 2017-03-01 | ||||
| 2014-12-31 | -$7.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$14.11M derived: sum of 2 quarters · filed 2017-03-01 | -$28.61M 10-K · filed 2017-03-01 | -$29.09M 10-K · filed 2015-03-25 | |
| 2014-09-30 | -$6.45M 10-Q · filed 2014-11-13 | -$20.95M 10-Q · filed 2014-11-13 | |||
| 2013-12-31 | -$5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$13.80M derived: sum of 2 quarters · filed 2016-03-14 | -$28.61M 10-K · filed 2016-03-14 | ||
| 2013-09-30 | -$8.22M 10-Q · filed 2014-11-13 | -$23.02M 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |